Nandurabolin |
Nandurabolin 25 mg / ml
25mg nandrolone decanoate
Company Name
El NileTherapeutic Group
ANABOLIC HORMONES PLAINPharmaceutical form
Solution for injection.Package
1 x 1ml ampoulesIndications
"For use in osteoporosis in post-menopausal women.Established osteoporosis should have been diagnosed by the following parameters:
i) Crush or wedge fractures of the vertebrae.
ii) Other osteoporotic fractures.
iii) Established reduction in bone mineral content as measured by accepted BMC measurements."
Product Type
HumanDosage
"Post-menopausal women : 50 mg every three weeks.The duration of treatment depends on the clinical response and the possible occurrence of side-effects.
We would recommend that the effectiveness of therapy be monitored with the appropriate methods for osteoporosis on a 6-12 monthly basis.
-Children:There are no recommendations for use in children.Administration: Deep intramuscular injection."
Adverse Reactions
"Virilisation which appears in sensitive women as hoarseness, acne, hirsutism and increase of libido;in prepubertal boys a and in girls as an increase of pubic hair and clitoral hypertrophy. Hoarseness may be the first symptom of vocalchange which may end in long-lasting, sometimes irreversible deepening of the voice.
-Amenorrhoea and inhibition of spermatogenesis.
-Premature epiphyseal closure.
-Sodium and water retention.
Contra Indications
Pregnancy , Nursing mothers &Pediatric use.Do not administer injections preserved with benzyl alcohol to neonates , infants below 13 years, pregnant women or nursing mothers. Benzyl alcoholhas been associated with serious adverse events& death, particularly in pediatric patients (it may cause Gasping syndrome). Injections preservative free should be used in these populations.Porphyria , allergies to any of the components and known or suspected carcinoma of prostate or mammary carcinoma in the male.Drug Interactions
Anabolic steroids may improve glucose tolerance and decrease the need for insulin or other antidiabetic drugs in diabetics.
No comments:
Post a Comment